Skip to main content
. 2023 Nov 16;77(10):229–239. [Article in Spanish] doi: 10.33588/rn.7710.2023063

Table I.

Variables related to demographic characteristics and prior history of patients.

Entire study sample (n = 238) COVID-19 related- headache (n = 143) COVID-19 vaccine related-headache (n = 95) FDR-corrected p-value
Median age, (SD) 35.5 (10.6) 36.2 (8.6) 30 (13) 0.438

Female sex, n (%) 180 (75.6%) 105 (73.4%) 75 (78.9%) 0.478

Prior history of headache, n (%) 32 (13.4%) 20 (14%) 12 (12.6%) 0.903

Family history of headache, n (%) 78 (32.8%) 33 (23.15) 45 (47.4%) <0.001

Family history of migraine, n (%) 67 (28.2%) 33 (23.1%) 34 (35.8%) 0.214

Hypertension, n (%) 7 (2.9%) 2 (1.4%) 5 (5.3%) 0.387

Diabetes. n (%) 7 (2.9%) 2 (1.4%) 5 (5.3%) 0.309

Smoking, n (%) 27 (11.3%) 19 (11.3%) 8 (8.4%) 0.557

Cardiological disorders, n (%) 7 (2.9%) 4 (2.8%) 3 (3.2%) 0.999

Pulmonary disorders, n (%) 9 (3.8%) 7 (4.9%) 2 (2.1%) 0.525

Oncological disorders, n (%) 6 (2.5%) 3 (2.1%) 3 (3.2%) 0.89

Neurological disorders, n (%) 9 (3.8%) 5 (3.5%) 4 (4.2%) 0.999

Immunosuppression, n (%) 3 (1.3%) 0 (0%) 3 (3.2%) 0.287

FDR: false discovery rate; SD: standard deviation.